Fund Holdings — BOONE CAPITAL MANAGEMENT LLC

Total Portfolio Value:
$383.41M
Total Bought:
$88.50M
Total Sold:
$172.29M
Net Transaction:
-$83.79M
Notable People:
Daniel Walter Boone
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Unum Group(UNM)1,025,027930,545-94,482$55.00M$47.56M12.40%-$7.44M
Globus Medical, Inc.CL A(GMED)529,825637,315+107,490$28.42M$43.65M11.38%+$15.23M
The Cigna Group(CI)131,926131,9260$47.91M$43.61M11.37%-$4.30M
Molina Healthcare, Inc.(MOH)85,71699,094+13,378$35.21M$29.46M7.68%-$5.75M
Danaher Corporation(DHR)65,811106,360+40,549$16.43M$26.57M6.93%+$10.14M
Baxter Intl Inc697,957721,278+23,321$29.83M$24.13M6.29%-$5.70M
IQVIA Holdings Inc.(IQV)094,734+94,734$0$20.03M5.22%+$20.03M
Amphastar Pharmaceuticals, Inc.(AMPH)606,688495,089-111,599$26.64M$19.80M5.17%-$6.84M
Mirum Pharmaceuticals, Inc.(MIRM)451,898523,679+71,781$11.35M$17.90M4.67%+$6.55M
Pennant Group Inc564,192699,966+135,774$11.08M$16.23M4.23%+$5.16M
Berry Global Group Inc450,101259,710-190,391$27.22M$15.28M3.99%-$11.94M
IDEAYA Biosciences, Inc.(IDYA)531,967422,049-109,918$23.34M$14.82M3.86%-$8.52M
Orthofix Medical Inc.(OFIX)974,502775,368-199,134$14.15M$10.28M2.68%-$3.87M
Charles River Laboratories International, Inc.(CRL)048,288+48,288$0$9.98M2.60%+$9.98M
Certara, Inc.(CERT)0718,983+718,983$0$9.96M2.60%+$9.96M
Xenon Pharmaceuticals Inc.(XENE)291,403250,460-40,943$12.54M$9.77M2.55%-$2.78M
Viking Therapeutics, Inc.(VKTX)310,462174,766-135,696$25.46M$9.26M2.42%-$16.19M
Healthcare Services Group, Inc.(HCSG)926,455873,018-53,437$11.56M$9.24M2.41%-$2.33M
Tarsus Pharmaceuticals, Inc.(TARS)609,104216,047-393,057$22.14M$5.87M1.53%-$16.27M
Bio Rad Labs IncCL A72,3440-72,344$25.02M$0—-$25.02M
Enovis Corporation(ENOV)562,7390-562,739$35.14M$0—-$35.14M
Mesa Laboratories, Inc.(MLAB)133,3940-133,394$14.64M$0—-$14.64M
Quanterix Corporation(QTRX)330,1510-330,151$7.78M$0—-$7.78M
Viatris Inc.(VTRS)1,133,5910-1,133,591$13.54M$0—-$13.54M
Page 1 of 1
BOONE CAPITAL MANAGEMENT LLC — 13F Holdings — Q2 2024 | TickerTrail